Oaktree Acquisition Corp. III Life Sciences

# Oaktree Acquisition Corp. III Life Sciences

This blank-check company, incorporated in 2024 and headquartered in Los Angeles, California, has no significant operating business. The company is structured as a special purpose acquisition vehicle (SPAC) and operates within the financial services sector. Its primary purpose is to identify and execute a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more operating companies.

The company has identified its intended target sectors as biopharmaceutical, medical devices, diagnostics, and specialized healthcare services businesses. Its geographic focus encompasses North America and Europe. Until such a transaction is consummated, the company generates no revenue and maintains minimal operational activity. The company does not have identifiable business segments or meaningful employee operations at present.